GlassScriptPhysician profile
Ashit C Patel
NPI 1477512614
$29,164.84
in general payments reported to CMS, 2019-2025
26 companies · $3,113 in 2025
The $3,113 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,666 · 2020: $1,953 · 2021: $1,593 · 2022: $3,724 · 2023: $3,469 · 2024: $7,646 · 2025: $3,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,945 · Food and Beverage: $5,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,944.57 |
| Food and Beverage | $5,284.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $6,261.63 | 2019-2024 | Excelsiusgps Robotic Navigation System, Rise-L . Rise-L A/L |
| Medtronic USA, INC. | $4,253.75 | 2019-2020 | |
| Si-Bone, INC. | $4,135.38 | 2019-2025 | |
| Cerapedics INC. | $2,823.44 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Providence Medical Technology, INC. | $2,781.31 | 2024-2025 | |
| Seaspine Orthopedics Corporation | $1,638.90 | 2022 | |
| Highridge Medical LLC | $1,330.53 | 2024 | Mobi-C Plug & Fit US, Roi-C |
| Centinel Spine, LLC | $1,268.22 | 2025 | Prodisc L |
| Medtronic, INC. | $1,078.07 | 2021-2025 | Osteocool Rf Ablation System, Stealthstation S8 Platform |
| Alphatec Spine, INC | $825.28 | 2022 | |
| Spineology INC. | $593.30 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $377.36 | 2019-2021 | |
| Abbott Laboratories | $285.64 | 2023 | Ensite Precision |
| Zimvie INC. | $235.02 | 2022-2023 | |
| Kuros Biosciences USA, INC | $180.51 | 2025 | Magnetos |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carlsmed, INC. | $177.09 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $160.53 | 2025 | |
| Augmedics INC. | $152.07 | 2024 | Xvision |
| Biocomposites INC | $143.69 | 2019-2021 | |
| Bioventus LLC | $137.70 | 2025 | |
| Organogenesis INC. | $116.84 | 2020 | |
| Integrity Implants INC. | $108.05 | 2022 | |
| Depuy Synthes Sales INC. | $46.54 | 2019-2021 | |
| Baxter Healthcare | $34.04 | 2023 | Floseal |
| Nuvasive, INC. | $19.95 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,083,051.93 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.